{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:08:55Z","timestamp":1772003335279,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10735-025-10668-0","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:48:54Z","timestamp":1768967334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative study of obeticholic acid and rosuvastatin in high-fat\/fructose diet\u2013induced metabolic dysfunction: role of AMPK, PPAR-\u03b3, SREBP-1c, and STAT3 pathways"],"prefix":"10.1007","volume":"57","author":[{"given":"Sahar M.","family":"Elashmony","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosra","family":"Alhindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7124-2758","authenticated-orcid":false,"given":"Dina H.","family":"Merzeban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa Mohamed","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariham George","family":"Loqa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan A.","family":"Shamardl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona Farag","family":"Shabana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"2","key":"10668_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/ijms18020285","volume":"18","author":"SM Alwahsh","year":"2017","unstructured":"Alwahsh SM, Dwyer BJ, Forbes S, Thiel DH, Lewis PJ, Ramadori G (2017) Insulin production and resistance in different models of diet-induced obesity and metabolic syndrome. Int J Mol Sci 18(2):285. https:\/\/doi.org\/10.3390\/ijms18020285","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10668_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00418-025-02402-4","volume":"163","author":"SM Alwahsh","year":"2025","unstructured":"Alwahsh SM, Xu M, Itmezeh A, Kim MH, Ramadori GP (2025) Excessive intake of fructose and alcohol aggravates high-fat diet-induced steatohepatitis and changes hepatic iron homeostasis. Histochem Cell Biol 163(1):77. https:\/\/doi.org\/10.1007\/s00418-025-02402-4","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"10668_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3892\/IJMM.14.2.207","volume":"14","author":"R Beloosesky","year":"2004","unstructured":"Beloosesky R, Gold R, Almog B et al (2004) Induction of polycystic ovary by testosterone in immature female rats: modulation of apoptosis and attenuation of glucose\/insulin ratio. Int J Mol Med 14(2):207\u2013215. https:\/\/doi.org\/10.3892\/IJMM.14.2.207","journal-title":"Int J Mol Med"},{"issue":"4","key":"10668_CR4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3390\/ijms19041197","volume":"19","author":"M Botta","year":"2018","unstructured":"Botta M, Audano M, Sahebkar A, Sirtori CR, Mitro N, Ruscica M (2018) PPAR agonists and metabolic syndrome: an established role? Int J Mol Sci 19(4):1197. https:\/\/doi.org\/10.3390\/ijms19041197","journal-title":"Int J Mol Sci"},{"key":"10668_CR5","doi-asserted-by":"publisher","DOI":"10.3945\/jn.109.111179","author":"KD Bruce","year":"2010","unstructured":"Bruce KD, Hanson MA (2010) The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr. https:\/\/doi.org\/10.3945\/jn.109.111179","journal-title":"J Nutr"},{"key":"10668_CR6","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00076.2017","author":"N Chukijrungroat","year":"2017","unstructured":"Chukijrungroat N, Khamphaya T, Weerachayaphorn J, Songserm T, Saengsirisuwan V (2017) Hepatic FGF21 mediates sex differences in high-fat high-fructose diet-induced fatty liver. Am J Physiol Endocrinol Metab. https:\/\/doi.org\/10.1152\/ajpendo.00076.2017","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10668_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1172\/JCI88883","volume":"127","author":"C Crewe","year":"2017","unstructured":"Crewe C, An YA, Scherer PE (2017) The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest 127(1):74\u201382. https:\/\/doi.org\/10.1172\/JCI88883","journal-title":"J Clin Invest"},{"issue":"8","key":"10668_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s40265-021-01510-4","volume":"81","author":"S Dehnavi","year":"2021","unstructured":"Dehnavi S, Kiani A, Sadeghi M, Biregani AF, Banach M, Atkin SL, Jamialahmadi T, Sahebkar A (2021) Targeting AMPK by statins: a potential therapeutic approach. Drugs 81(8):923\u2013933. https:\/\/doi.org\/10.1007\/s40265-021-01510-4","journal-title":"Drugs"},{"issue":"2","key":"10668_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1194\/jlr.M070888","volume":"58","author":"B Dong","year":"2017","unstructured":"Dong B, Young M, Liu X, Singh AB, Liu J (2017) Regulation of lipid metabolism by obeticholic acid in hyperlipidemic hamsters. J Lipid Res 58(2):350\u2013363. https:\/\/doi.org\/10.1194\/jlr.M070888","journal-title":"J Lipid Res"},{"issue":"2","key":"10668_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.21608\/zvjz.2023.189986.1206","volume":"51","author":"S El Nabtity","year":"2023","unstructured":"El Nabtity S, Eleiwa NZ, Kamel MA, Fahmy AA (2023) Hyperlipidemia: methods of induction and possible treatments. Zagazig Vet J 51(2):169\u2013184. https:\/\/doi.org\/10.21608\/zvjz.2023.189986.1206","journal-title":"Zagazig Vet J"},{"key":"10668_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.970292","author":"C Fang","year":"2022","unstructured":"Fang C, Pan J, Qu N, Lei Y, Han J, Zhang J, Han D (2022) The AMPK pathway in fatty liver disease. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2022.970292","journal-title":"Front Physiol"},{"key":"10668_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1476-511X-10-165","volume":"10","author":"PG Fassini","year":"2011","unstructured":"Fassini PG, Noda RW, Ferreira ES, Silva MA, Neves VA, Demonte A (2011) Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats. Lipids Health Dis 10:165. https:\/\/doi.org\/10.1186\/1476-511X-10-165","journal-title":"Lipids Health Dis"},{"key":"10668_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01275.x","author":"P Ferr\u00e9","year":"2010","unstructured":"Ferr\u00e9 P, Foufelle F (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab. https:\/\/doi.org\/10.1111\/j.1463-1326.2010.01275.x","journal-title":"Diabetes Obes Metab"},{"key":"10668_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102464","author":"A Floreani","year":"2022","unstructured":"Floreani A, Gabbia D, De Martin S (2022) Obeticholic acid for primary biliary cholangitis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10102464","journal-title":"Biomedicines"},{"key":"10668_CR15","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1365","author":"A Fukushima","year":"2010","unstructured":"Fukushima A, Loh K, Galic S, Fam B, Shields B, Wiede F, Tremblay ML, Watt MJ, Andrikopoulos S, Tiganis T (2010) T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis. Diabetes. https:\/\/doi.org\/10.2337\/db09-1365","journal-title":"Diabetes"},{"issue":"1","key":"10668_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/2314808X.2023.2245618","volume":"10","author":"AA Gadallah","year":"2023","unstructured":"Gadallah AA, Almasari AR (2023) The effects of a high-fat diet on the liver of pregnant albino rats and their developing offspring. Egypt J Basic Appl Sci 10(1):567\u2013579. https:\/\/doi.org\/10.1080\/2314808X.2023.2245618","journal-title":"Egypt J Basic Appl Sci"},{"issue":"1","key":"10668_CR17","doi-asserted-by":"publisher","first-page":"8157","DOI":"10.1038\/s41598-018-26383-8","volume":"8","author":"T Goto","year":"2018","unstructured":"Goto T, Itoh M, Suganami T, Kanai S, Shirakawa I, Sakai T, Asakawa M, Yoneyama T, Kai T, Ogawa Y (2018) Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis. Sci Rep 8(1):8157. https:\/\/doi.org\/10.1038\/s41598-018-26383-8","journal-title":"Sci Rep"},{"issue":"6","key":"10668_CR18","doi-asserted-by":"publisher","first-page":"e0286726","DOI":"10.1371\/journal.pone.0286726","volume":"18","author":"DS Graham","year":"2023","unstructured":"Graham DS, Liu G, Arasteh A, Yin X-M, Yan S (2023) Ability of high fat diet to induce liver pathology correlates with the level of linoleic acid and Vitamin E in the diet. PLoS ONE 18(6):e0286726. https:\/\/doi.org\/10.1371\/journal.pone.0286726","journal-title":"PLoS ONE"},{"issue":"5","key":"10668_CR19","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","volume":"175","author":"M Grohmann","year":"2018","unstructured":"Grohmann M, Wiede F, Dodd GT, Gurzov EN, Ooi GJ, Butt T, Rasmiena AA, Kaur S, Gulati T, Goh PK, Treloar AE, Archer S, Brown WA, Muller M, Watt MJ, Ohara O, McLean CA, Tiganis T (2018) Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC. Cell 175(5):1289-1306.e20. https:\/\/doi.org\/10.1016\/j.cell.2018.09.053","journal-title":"Cell"},{"issue":"1","key":"10668_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/oby.21701","volume":"25","author":"F Haczeyni","year":"2017","unstructured":"Haczeyni F, Poekes L, Wang H, Mridha AR, Barn V, Haigh WG, Ioannou GN, Yeh MM, Leclercq IA, Teoh NC, Farrell GC (2017) Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice. Obesity 25(1):155\u2013165. https:\/\/doi.org\/10.1002\/oby.21701","journal-title":"Obesity"},{"key":"10668_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.atherosclerosissup.2018.04.196","volume":"32","author":"SM Hewage","year":"2018","unstructured":"Hewage SM, Sid V, Prashar S, Shang Y, Karmin O, Siow YL (2018) Impact of lingonberry supplementation on high-fat diet induced metabolic syndrome and hyperlipidemia. Atheroscler Suppl 32:65","journal-title":"Atheroscler Suppl"},{"issue":"3","key":"10668_CR22","first-page":"4514","volume":"15","author":"ZS Hussain","year":"2021","unstructured":"Hussain ZS, Al-Awadi JHH (2021) A comparative study between rosuvastatin and nanorosuvastatin effects on liver in mice that consuming diets rich in vegetable oil. Indian J Forensic Med Toxicol 15(3):4514\u20134521","journal-title":"Indian J Forensic Med Toxicol"},{"key":"10668_CR23","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2022.0230","author":"RJ Johnson","year":"2023","unstructured":"Johnson RJ, Lanaspa MA, Sanchez-Lozada LG, Tolan D, Nakagawa T, Ishimoto T, Andres-Hernando A, Rodriguez-Iturbe B, Stenvinkel P (2023) The fructose survival hypothesis for obesity. Philos Trans R Soc Lond B Biol Sci. https:\/\/doi.org\/10.1098\/rstb.2022.0230","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"10668_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jhep.2020.07.035","volume":"74","author":"K Kj\u00e6rgaard","year":"2021","unstructured":"Kj\u00e6rgaard K, Frisch K, S\u00f8rensen MM, Munk OL, Hofmann AF, Horsager J, Schacht AC, Erickson M, Shapiro D, Keiding S (2021) Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis. J Hepatol 74(1):58\u201365. https:\/\/doi.org\/10.1016\/j.jhep.2020.07.035","journal-title":"J Hepatol"},{"key":"10668_CR25","first-page":"551","volume":"84","author":"AR Last","year":"2011","unstructured":"Last AR, Ference JD, Falleroni J (2011) Pharmacologic treatment of hyperlipidemia. Am Fam Physician 84:551\u2013558","journal-title":"Am Fam Physician"},{"issue":"1","key":"10668_CR26","doi-asserted-by":"publisher","first-page":"e220155","DOI":"10.1530\/JOE-22-0155","volume":"257","author":"SM Lee","year":"2023","unstructured":"Lee SM, Muratalla J, Sierra-Cruz M, Cordoba-Chacon J (2023) Role of hepatic peroxisome proliferator-activated receptor\u202f? in NAFLD. J Endocrinol 257(1):e220155. https:\/\/doi.org\/10.1530\/JOE-22-0155","journal-title":"J Endocrinol"},{"issue":"10","key":"10668_CR27","doi-asserted-by":"publisher","first-page":"976","DOI":"10.2174\/1389203720666190726152847","volume":"20","author":"C Li","year":"2019","unstructured":"Li C, Li Y, Gai Z (2019) Bile acids and farnesoid X receptor: novel target for the treatment of diabetic cardiomyopathy. Curr Protein Pept Sci 20(10):976\u2013983. https:\/\/doi.org\/10.2174\/1389203720666190726152847","journal-title":"Curr Protein Pept Sci"},{"issue":"4","key":"10668_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2???CT method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"key":"10668_CR29","first-page":"6","volume":"24","author":"JZ Lyu","year":"2020","unstructured":"Lyu JZ, Xu YJ, Hus P, Feng GF, Huang YH, Deng YJ, Wang X (2020a) Effect of Shenling Baizhusan on mTORC1\/STAT3 pathway in hepatocytes of nonalcoholic fatty liver disease rats. Zhongguo Shiyan Fangji Xueza Zhi 24:6\u201312","journal-title":"Zhongguo Shiyan Fangji Xueza Zhi"},{"key":"10668_CR30","first-page":"6","volume":"24","author":"J-Z Lyu","year":"2020","unstructured":"Lyu J-Z, Xu Y-J, Hus P, Feng G-F, Huang Y-H, Deng Y-J, Wang X (2020b) Effect of Shenling Baizhusan on mTORC1\/STAT3 Pathway in Hepatocytes of Nonalcoholic Fatty Liver Disease Rats. Chinese J Experiment Tradition Med Formulae 24:6\u201312","journal-title":"Chinese J Experiment Tradition Med Formulae"},{"issue":"9","key":"10668_CR31","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/hepr.12821","volume":"47","author":"TDS Marinho","year":"2017","unstructured":"Marinho TDS, Kawasaki A, Bryntesson M, Souza-Mello V, Barbosa-da-Silva S, Aguila MB, Mandarim-de-Lacerda CA (2017) Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice. Hepatol Res 47(9):928\u2013940. https:\/\/doi.org\/10.1111\/hepr.12821","journal-title":"Hepatol Res"},{"issue":"2","key":"10668_CR32","doi-asserted-by":"publisher","first-page":"E399","DOI":"10.1152\/ajpendo.00407.2018","volume":"317","author":"S McIlvride","year":"2019","unstructured":"McIlvride S, Nikolova V, Fan HM, McDonald JAK, Wahlstr\u00f6m A, Bellafante E, Jansen E, Adorini L, Shapiro D, Jones P, Marchesi JR, Marschall HU, Williamson C (2019) Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes. Am J Physiol Endocrinol Metab 317(2):E399\u2013E410. https:\/\/doi.org\/10.1152\/ajpendo.00407.2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10668_CR33","doi-asserted-by":"publisher","first-page":"111839","DOI":"10.1016\/j.mce.2022.111839","volume":"562","author":"CS Miranda","year":"2023","unstructured":"Miranda CS, Silva-Veiga FM, Fernandes-da-Silva A, Guimar\u00e3es Pereira VR, Martin BC, Daleprane JB, Martins FF, Souza-Mello V (2023) Peroxisome proliferator-activated receptors-alpha and gamma synergism modulate the gut-adipose tissue axis and mitigate obesity. Mol Cell Endocrinol 562:111839. https:\/\/doi.org\/10.1016\/j.mce.2022.111839","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10668_CR34","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.amjcard.2012.12.037","volume":"111","author":"EP Navarese","year":"2013","unstructured":"Navarese EP, Buffon A, Andreotti F, Kozinski M, Welton N, Fabiszak T, Caputo S, Grzesk G, Kubica A, Swiatkiewicz I, Sukiennik A, Kelm M, De Servi S, Kubica J (2013) Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol 111(8):1123\u20131130. https:\/\/doi.org\/10.1016\/j.amjcard.2012.12.037","journal-title":"Am J Cardiol"},{"issue":"5","key":"10668_CR35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/ph15050524","volume":"15","author":"G Palladini","year":"2022","unstructured":"Palladini G, Cagna M, Di Pasqua LG, Adorini L, Croce AC, Perlini S, Ferrigno A, Berardo C, Vairetti M (2022) Obeticholic acid reduces kidney matrix metalloproteinase activation following partial hepatic ischemia\/reperfusion injury in rats. Pharmaceuticals 15(5):524. https:\/\/doi.org\/10.3390\/ph15050524","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10668_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ajpath.2020.09.011","volume":"191","author":"D Pilling","year":"2021","unstructured":"Pilling D, Karhadkar TR, Gomer RH (2021) High-fat diet-induced adipose tissue and liver inflammation and steatosis in mice are reduced by inhibiting sialidases. Am J Pathol 191(1):131\u2013143. https:\/\/doi.org\/10.1016\/j.ajpath.2020.09.011","journal-title":"Am J Pathol"},{"key":"10668_CR37","doi-asserted-by":"publisher","first-page":"40281","DOI":"10.1007\/s11356-022-19733-7","volume":"29","author":"A Rauf","year":"2022","unstructured":"Rauf A, Akram M, Anwar H, Daniyal M, Munir N, Bawazeer S, Rebezov M, Bouyahya A, Shariati M, Khan H (2022) Therapeutic potential of herbal medicine for the management of hyperlipidemia: latest updates. Environ Sci Pollut Res 29:40281\u201340301","journal-title":"Environ Sci Pollut Res"},{"issue":"9841","key":"10668_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","volume":"380","author":"PM Ridker","year":"2012","unstructured":"Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ (2012) Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 380(9841):565\u2013571. https:\/\/doi.org\/10.1016\/S0140-6736(12)61190-8","journal-title":"Lancet"},{"key":"10668_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67227","author":"NB Ruderman","year":"2013","unstructured":"Ruderman NB, Carling D, Prentki M, Cacicedo JM (2013) AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI67227","journal-title":"J Clin Invest"},{"key":"10668_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151592","author":"VA Salunkhe","year":"2016","unstructured":"Salunkhe VA, Elvstam O, Eliasson L, Wendt A (2016) Rosuvastatin treatment affects both basal and glucose-induced insulin secretion in INS-1 832\/13 cells. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0151592","journal-title":"PLoS ONE"},{"issue":"4","key":"10668_CR41","doi-asserted-by":"publisher","first-page":"e70152","DOI":"10.1002\/mco2.70152","volume":"6","author":"MA Samad","year":"2025","unstructured":"Samad MA, Ahmad I, Hasan A, Alhashmi MH, Ayub A, Al-Abbasi FA, Kumer A, Tabrez S (2025) STAT3 signaling pathway in health and disease. MedComm (2020) 6(4):e70152. https:\/\/doi.org\/10.1002\/mco2.70152","journal-title":"MedComm (2020)"},{"issue":"5","key":"10668_CR42","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jhep.2023.07.014","volume":"79","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal AJ, Ratziu V, Loomba R, Leyva R, Harrison SA et al (2023) Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis. J Hepatol 79(5):1110\u20131120. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.014","journal-title":"J Hepatol"},{"issue":"4","key":"10668_CR43","first-page":"275","volume":"10","author":"SH Seif el-Din","year":"2015","unstructured":"Seif el-Din SH, El-Lakkany NM, El-Naggar AA, Hammam OA, Abd El-Latif HA, Ain-Shoka AA, Ebeid FA (2015) Effects of rosuvastatin and\/or \u03b2-carotene on non-alcoholic fatty liver in rats. Res Pharm Sci 10(4):275\u2013287","journal-title":"Res Pharm Sci"},{"key":"10668_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-023-00458-y","author":"HAMA Shamardl","year":"2023","unstructured":"Shamardl HAMA, Ibrahim NA, Merzeban DH, Elamir AM, Golam RM, Elsayed AM (2023) Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: role of SIRT-1 \/ adipokines \/ PPAR\u03b3 and IGF-1. DARU J Pharm Sci. https:\/\/doi.org\/10.1007\/s40199-023-00458-y","journal-title":"DARU J Pharm Sci"},{"issue":"1","key":"10668_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhep.2019.10.006","volume":"72","author":"MS Siddiqui","year":"2020","unstructured":"Siddiqui MS, Van Natta ML, Connelly MA, Vuppalanchi R, Neuschwander-Tetri BA, Tonascia J, Guy C, Loomba R, Dasarathy S, Wattacheril J, Chalasani N, Sanyal AJ, NASH CRN (2020) Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis. J Hepatol 72(1):25\u201333. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.006","journal-title":"J Hepatol"},{"issue":"1","key":"10668_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.21608\/ejh.2021.58761.1421","volume":"45","author":"HA Sorour","year":"2022","unstructured":"Sorour HA, Salem MA, Abdelmaksoud DA, Abd Elgalil MM (2022) The impact of high fat diet and flaxseed on liver histology, histochemistry and morphometry in ovariectomized Albino rat. Egypt J Histol 45(1):68\u201389. https:\/\/doi.org\/10.21608\/ejh.2021.58761.1421","journal-title":"Egypt J Histol"},{"key":"10668_CR47","unstructured":"Suvarna SK, Layton C, & Bancroft JD (2018) Bancroft\u2019s Theory and Practice of Histological Techniques, Eighth Edition. In Bancroft\u2019s Theory and Practice of Histological Techniques, Eighth Edition"},{"key":"10668_CR48","doi-asserted-by":"crossref","unstructured":"Toprak K, Mustafa K, Mesut K, Ayten D, Yakup A, Mustafa BT, Asuman B, & Recep D (2024) Atherogenic Combined Index: Validation of a Coronary Artery Disease Predictive Biomarker. Archives of Medical Research","DOI":"10.1016\/j.arcmed.2024.103065"},{"key":"10668_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/srep33453","author":"L Verbeke","year":"2016","unstructured":"Verbeke L, Mannaerts I, Schierwagen R, Govaere O, Klein S, Vander Elst I, Windmolders P, Farre R, Wenes M, Mazzone M, Nevens F, Van Grunsven LA, Trebicka J, Laleman W (2016) FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Sci Rep. https:\/\/doi.org\/10.1038\/srep33453","journal-title":"Sci Rep"},{"issue":"9","key":"10668_CR50","doi-asserted-by":"publisher","first-page":"103126","DOI":"10.1016\/j.dsx.2024.103126","volume":"18","author":"X Wang","year":"2024","unstructured":"Wang X, Lyu L, Li W, Xu L, Zhang H, Wang S, Liu Y, Ping F, Li Y (2024) Impact of rosuvastatin on metabolic syndrome patients with moderate to severe metabolic associated fatty liver disease without overt diabetes: a randomized clinical trial. Diabetes Metab Syndr 18(9):103126. https:\/\/doi.org\/10.1016\/j.dsx.2024.103126","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10668_CR51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40360-022-00595-1","volume":"23","author":"D Xilifu","year":"2022","unstructured":"Xilifu D, Tuerxun Z, Nuermaimaiti B, Aili A, Rehemu N, Sun H, Zhang X (2022) Effects of rosuvastatin on serum glucose and insulin in hyperuricemic rats. BMC Pharmacol Toxicol 23(1):66. https:\/\/doi.org\/10.1186\/s40360-022-00595-1","journal-title":"BMC Pharmacol Toxicol"},{"key":"10668_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-019-1171-8","volume":"19","author":"YS Yao","year":"2020","unstructured":"Yao YS, Li TD, Zeng ZH (2020) Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review. Lipids Health Dis 19:1\u20136","journal-title":"Lipids Health Dis"},{"issue":"10","key":"10668_CR53","doi-asserted-by":"publisher","first-page":"e10896","DOI":"10.1016\/j.heliyon.2022.e10896","volume":"8","author":"I Yustisia","year":"2022","unstructured":"Yustisia I, Tandiari D, Cangara MH, Hamid F, Daud NA (2022) A high-fat, high-fructose diet induced hepatic steatosis, renal lesions, dyslipidemia, and hyperuricemia in non-obese rats. Heliyon 8(10):e10896. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10896","journal-title":"Heliyon"},{"issue":"3","key":"10668_CR54","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3892\/etm.2021.10423","volume":"22","author":"H Zhang","year":"2021","unstructured":"Zhang H, Dong M, Liu X (2021) Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat. Exp Ther Med 22(3):991. https:\/\/doi.org\/10.3892\/etm.2021.10423","journal-title":"Exp Ther Med"},{"key":"10668_CR55","doi-asserted-by":"publisher","first-page":"100224","DOI":"10.1016\/j.aohep.2020.06.010","volume":"21","author":"J Zhao","year":"2021","unstructured":"Zhao J, Qi Y-F, Yu Y-R (2021) STAT3: a key regulator in liver fibrosis. Ann Hepatol 21:100224. https:\/\/doi.org\/10.1016\/j.aohep.2020.06.010","journal-title":"Ann Hepatol"},{"key":"10668_CR56","doi-asserted-by":"publisher","first-page":"114024","DOI":"10.1016\/j.biopha.2022.114024","volume":"157","author":"P Zheng","year":"2023","unstructured":"Zheng P, Wu H, Gu Y, Li L, Hu R, Ma W, Bian Z, Liu N, Yang D, Chen X (2023) Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3\/CPT1 pathway. Biomed Pharmacother 157:114024. https:\/\/doi.org\/10.1016\/j.biopha.2022.114024","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10668_CR57","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.3390\/cells10082072","volume":"10","author":"T Zhou","year":"2021","unstructured":"Zhou T, Kundu D, Kundu D, Robles-Linares J, Meadows V, Sato K, Baiocchi L, Ekser B et al (2021) Feedback signaling between cholangiopathies, ductular reaction, and non-alcoholic fatty liver disease. Cells 10(8):2072. https:\/\/doi.org\/10.3390\/cells10082072","journal-title":"Cells"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10668-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10668-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10668-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:24:15Z","timestamp":1772000655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10668-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10668"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10668-0","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript describes original work that has not been submitted or published in any other peer-reviewed journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior publication"}}],"article-number":"58"}}